Free Newsletter
Pioneering Pharma/IT deals target outcomes
Drugmakers are cozying up to IT companies to better make the case for their products. "This movement will be driven by a focus on outcomes," says Patrick Flochel of Ernst & Young. Novartis, for example, is working on "smart pills" that transmit data from inside the body to monitor patients' vital signs and check whether they have taken medicines as prescribed. Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: